4-1718171-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001127266.2(TMEM129):āc.661G>Cā(p.Val221Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000172 in 1,571,684 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001127266.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM129 | NM_001127266.2 | c.661G>C | p.Val221Leu | missense_variant | 2/4 | ENST00000382936.8 | NP_001120738.1 | |
TMEM129 | NM_138385.4 | c.661G>C | p.Val221Leu | missense_variant | 2/3 | NP_612394.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM129 | ENST00000382936.8 | c.661G>C | p.Val221Leu | missense_variant | 2/4 | 1 | NM_001127266.2 | ENSP00000372394.3 | ||
TMEM129 | ENST00000303277.6 | c.661G>C | p.Val221Leu | missense_variant | 2/3 | 1 | ENSP00000305243.2 | |||
TMEM129 | ENST00000460722.1 | n.64G>C | non_coding_transcript_exon_variant | 1/3 | 1 | ENSP00000417412.1 | ||||
TACC3 | ENST00000458173.4 | c.-2+5006C>G | intron_variant | 5 | ENSP00000415914.4 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152234Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000183 AC: 26AN: 1419450Hom.: 0 Cov.: 31 AF XY: 0.0000199 AC XY: 14AN XY: 702630
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152234Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 04, 2022 | The c.661G>C (p.V221L) alteration is located in exon 2 (coding exon 2) of the TMEM129 gene. This alteration results from a G to C substitution at nucleotide position 661, causing the valine (V) at amino acid position 221 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at